Get the Stockscreener App
127.78
0.58%
-0.75
After Hours:
127.80
0.02
+0.02%
Mesa Laboratories Inc stock is traded at $127.78, with a volume of 100.55K.
It is down -0.58% in the last 24 hours and up +26.34% over the past month.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
See More
Previous Close:
$128.53
Open:
$126.09
24h Volume:
100.55K
Relative Volume:
0.50
Market Cap:
$715.04M
Revenue:
$249.13M
Net Income/Loss:
$6.71M
P/E Ratio:
105.81
EPS:
1.2076
Net Cash Flow:
$39.58M
1W Performance:
-1.01%
1M Performance:
+26.34%
6M Performance:
+37.65%
1Y Performance:
+98.63%
1-Day Range:
$125.35
$128.29
1-Week Range:
$123.59
$132.70
52-Week Range:
$58.83
$132.70
Mesa Laboratories Inc Stock (MLAB) Company Profile
Name
Mesa Laboratories Inc
Sector
Phone
(303) 987-8000
Address
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs KEYS, COHR, GRMN, TDY, MKSI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
127.78 | 666.75M | 249.13M | 6.71M | 39.58M | 1.2076 |
KEYS
Keysight Technologies Inc
|
327.21 | 53.90B | 6.09B | 1.07B | 1.36B | 6.0693 |
COHR
Coherent Corp
|
281.86 | 56.80B | 6.60B | 452.58M | -538.24M | 2.0946 |
GRMN
Garmin Ltd
|
277.03 | 56.52B | 7.46B | 1.74B | 1.45B | 8.9685 |
TDY
Teledyne Technologies Inc
|
610.65 | 29.39B | 6.22B | 933.70M | 1.05B | 19.76 |
MKSI
Mks Inc
|
260.31 | 19.06B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-02-20 | Initiated | JP Morgan | Neutral |
| Dec-04-19 | Initiated | Jefferies | Buy |
| Aug-26-19 | Initiated | Evercore ISI | Outperform |
| Jun-10-16 | Downgrade | Sidoti | Buy → Neutral |
View All
Mesa Laboratories Inc Stock (MLAB) Latest News
Is Mesa Laboratories Inc (MLAB) Overvalued After 4.5% Rally? GF - GuruFocus
Former Mesa Labs (MLAB) exec files notice for August stock sale - Stock Titan
Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript - AOL.com
Mesa Laboratories (NASDAQ:MLAB) Reaches New 52-Week HighWhat's Next? - MarketBeat
Mesa (MLAB) Results Versus Estimates: The Bottom-Line Figure Outpaces Its Comparison at the Close; Share Response: The Market Price Advances 0.28% in Latest TradingEPS Growth Rate - Vinanet
Mesa Labs director John Sullivan sells $800,090 in stock By Investing.com - Investing.com Nigeria
Mesa Laboratories Director Shiraz Ladiwala Receives 3,810 Shares from RSU Vesting on August 15, 2026 - Kalkine Media
Mesa Laboratories (NASDAQ: MLAB) director adds 2,784 shares via RSU vesting - Stock Titan
Mesa Labs (NASDAQ: MLAB) director adds 2,784 shares from RSUs - Stock Titan
Mesa Labs (NASDAQ: MLAB) director settles 3,810 RSUs into stock - Stock Titan
Mesa Laboratories (NASDAQ: MLAB) director now holds 6,973 shares - Stock Titan
Mesa Laboratories (NASDAQ: MLAB) director adds stock via RSU vesting - Stock Titan
Mesa Labs (MLAB) director’s equity grant adds 2,784 shares - Stock Titan
Mesa Laboratories CEO Kadia buys $800,090 in stock By Investing.com - Investing.com South Africa
Siddhartha Kadia Buys 7,093 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock - MarketBeat
R Tony Tripeny Acquires 900 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock - MarketBeat
Mesa Labs director John Sullivan sells $800,090 in stock - Investing.com
MLAB Q2 2026 Earnings: EPS of $2.61 Crushes Estimates by 8,429%Pretax Income Report - vinanet.vn
Mesa Laboratories CEO Kadia buys $800,090 in stock - Investing.com
Mesa Laboratories (NASDAQ: MLAB) director sells shares to CEO - Stock Titan
Mesa Laboratories (NASDAQ: MLAB) director lifts stake to 6,298 shares - Stock Titan
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Mesa Laboratories, Inc. $MLAB - MarketBeat
Mesa Labs director John James Sullivan disposes of 7,093 common shares for $799,790.4 - Bitget
Mesa Laboratories (NASDAQ:MLAB) Rating Lowered to Buy at Wall Street Zen - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 6%Time to Sell? - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Given New $110.00 Price Target at Wells Fargo & Company - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month HighHere's Why - MarketBeat
Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB - MarketBeat
Mesa Labs (NASDAQ: MLAB) CEO trust buys shares from board chair - Stock Titan
Mesa Laboratories (MLAB) Stock Jumps As Margin Gains Meet Backlog Doubts - Sahm
Mesa Labs Posts Margin Surge, Pays Down $8.7 Million in Debt as New CEO Tackles Delivery Delays - finance.biggo.com
Mesa Laboratories (NASDAQ:MLAB) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: Margin Expansion and Debt ... - Yahoo Finance
Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: - GuruFocus
Mesa Labs Q1 Results: Operating Income Jumps 129% To $7,031 - scanx.trade
Mesa Laboratories Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Mesa Laboratories posts Q1 2026 revenue miss By Investing.com - Investing.com Nigeria
Mesa Laboratories Q1 Adj EPS beats estimates by 11.67% - scanx.trade
Mesa Laboratories (MLAB) Releases Q1 2027 Earnings: Revenue Growth but EPS Declines - Quiver Quantitative
Mesa Laboratories Announces Q1 Fiscal 2027 Earnings with Increased Operating Income Despite Net Income Decline - Kalkine Media
Earnings call transcript: Mesa Laboratories posts Q1 2026 revenue miss - Investing.com
Mesa Laboratories Inc /Co/ 2026: Revenue $60.14M, EPS $0.49— 10-Q Summary - TradingView
Mesa Laboratories (MLAB) lifts Q1 margins and cash flow while net income falls - Stock Titan
Is Mesa Laboratories Inc (MLAB) Undervalued After Q1 Earnings Mi - GuruFocus
Mesa Laboratories, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Mesa Laboratories (NASDAQ:MLAB) Issues Earnings Results, Misses Expectations By $2.14 EPS - MarketBeat
Q1 2027 Mesa Laboratories Inc Earnings Call Transcript - GuruFocus
Mesa Labs: Fiscal Q1 Earnings Snapshot - marketscreener.com
Mesa Labs Announces First Quarter Results - GlobeNewswire
Renaissance Technologies LLC Has $2.79 Million Holdings in Mesa Laboratories, Inc. $MLAB - MarketBeat
Mesa Laboratories Inc Stock (MLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):